SP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.09120001923202E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.81479999999646E-05 |
Normal-vs-Stage2 |
5.0336000001483E-07 |
Normal-vs-Stage3 |
5.44608802499624E-12 |
Normal-vs-Stage4 |
1.84041670792112E-12 |
Stage1-vs-Stage2 |
1.321570E-02 |
Stage1-vs-Stage3 |
1.92075999999597E-05 |
Stage1-vs-Stage4 |
4.33590000015194E-07 |
Stage2-vs-Stage3 |
5.485600E-01 |
Stage2-vs-Stage4 |
1.445830E-01 |
Stage3-vs-Stage4 |
2.474200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.16729967306151E-11 |
Normal-vs-AfricanAmerican |
3.158000E-02 |
Normal-vs-Asian |
5.326400E-01 |
Caucasian-vs-AfricanAmerican |
6.141600E-02 |
Caucasian-vs-Asian |
7.834100E-02 |
AfricanAmerican-vs-Asian |
6.256800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.33895150311992E-12 |
Normal-vs-Female |
7.52620000000759E-05 |
Male-vs-Female |
8.767400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.157500E-03 |
Normal-vs-Age(41-60Yrs) |
3.36439999970573E-07 |
Normal-vs-Age(61-80Yrs) |
4.98060037656956E-10 |
Normal-vs-Age(81-100Yrs) |
4.35569999956975E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.034200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.023600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.994000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.300820E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.310100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.468800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.502250E-02 |
Normal-vs-Grade 2 |
4.29640000000342E-05 |
Normal-vs-Grade 3 |
2.01527683429958E-12 |
Normal-vs-Grade 4 |
1.63014046705712E-12 |
Grade 1-vs-Grade 2 |
2.14649999999983E-05 |
Grade 1-vs-Grade 3 |
9.80429959440698E-10 |
Grade 1-vs-Grade 4 |
1.54819490560953E-11 |
Grade 2-vs-Grade 3 |
3.58649999999683E-05 |
Grade 2-vs-Grade 4 |
1.0622000001792E-07 |
Grade 3-vs-Grade 4 |
1.596150E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.97299999999246E-05 |
Normal-vs-ccB subtype |
1.45230494297266E-11 |
ccA subtype-vs-ccB subtype |
1.39170000001965E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.28230004392549E-09 |
Normal-vs-N1 |
4.30309999999157E-06 |
N0-vs-N1 |
1.187000E-01 |
|
|